Compounded tirzepatide is tirzepatide prepared by a state-licensed compounding pharmacy for an individual prescription, rather than manufactured by Eli Lilly under an FDA approval.
What compounded tirzepatide is
Compounding is when a pharmacy mixes a drug for a specific patient. During the shortage of Zepbound and Mounjaro, FDA allowed pharmacies to make copies. That window has closed [2]. Compounded tirzepatide is not FDA-approved, and FDA does not review it for safety, effectiveness or quality before it is sold [1]. It is not interchangeable with Zepbound or Mounjaro, and FDA tells telehealth companies not to imply that it is [5].
Some compounded products add other ingredients. FDA's Sept 18, 2026 warning letter to Empower Pharmacy, a large compounder, called its tirzepatide-with-niacinamide products "essentially copies" of the approved drug [6].
Is compounded tirzepatide legal? The timeline
| Date | What happened | Source |
|---|---|---|
| Oct 2, 2024 | FDA first finds the tirzepatide shortage resolved | [2] |
| Oct 22, 2024 | FDA takes the decision back for review after the Outsourcing Facilities Association sues | [2] |
| Dec 19, 2024 | FDA again declares the shortage resolved | [2] |
| March 5, 2025 | Tolerance for 503A pharmacy compounding ends when a Texas federal court denies an injunction | [2] |
| March 19, 2025 | Tolerance for 503B outsourcing facilities ends | [2] |
| Sept 5, 2025 | FDA "green list" import alert: GLP-1 ingredients from unlisted plants can be held at the border | [7] |
| Sept 9, 2025 | FDA warning letters to telehealth firms, including several selling compounded tirzepatide | [8] |
| Feb 6, 2026 | FDA says it will act against non-approved GLP-1 ingredients and warns of seizures and injunctions | [9] |
| March 3, 2026 | FDA announces 30 more telehealth warning letters (dated Feb 20) | [10] |
| June 8, 2026 | 25 more telehealth warning letters, posted June 16 | [11] |
| Aug 27, 2026 | Fifth Circuit upholds FDA's shortage decision (No. 25-10600) | [12] |
| Sept 18, 2026 | Warning letter to Empower Pharmacy over tirzepatide blends | [6] |
What is still allowed
- 503A pharmacies may compound for an individual patient's prescription. Copies of an approved drug are barred unless the prescriber decides and documents that a change makes a significant difference for that patient [2].
- FDA says it does not intend to act against a 503A pharmacy that fills four or fewer copy prescriptions a month, and it may still act on unsafe or substandard products [2].
- 503B outsourcing facilities cannot compound tirzepatide from bulk ingredient: it is on neither the 503B bulks list nor the shortage list [2].
That is how online sellers still offer it: prescriptions are written as "personalized," sometimes with a vitamin added. FDA's Empower letter rejected that approach when the "significant difference" notes were missing or copied word for word, and said platform menus "call the individualized nature of those determinations into question" [6]. The Fifth Circuit found FDA reasonably relied on Lilly's supply data, which showed an 11.6 million-dose surplus by November 2024 [13].
Is it going away?
Nobody can give a date. The court fight over the shortage ended in FDA's favor on Aug 27, 2026 [12], FDA has said it will restrict the ingredients [9], and letters keep coming. We could not confirm whether the challengers asked for further review. Track new letters on our FDA warning letter tracker.
Is compounded tirzepatide safe?
FDA cannot vouch for it because it does not review these products. Its reasons for concern [1]:
- More than 730 adverse event reports for compounded tirzepatide as of May 31, 2026, likely undercounted because 503A pharmacies do not have to report.
- Dosing errors with compounded GLP-1 vials, some needing hospital care, from patients mismeasuring doses and clinicians miscalculating them.
- Ingredients of unknown origin: FDA's green list lets it detain GLP-1 ingredients from plants not on the list [7].
The Empower letter also cited insanitary conditions and manufacturing failures at that pharmacy [6]. Ask any program which pharmacy compounds your drug, and check it.
Does it work?
We found no published trials of compounded tirzepatide products in the sources we reviewed, so their effect is unknown. The trial results people quote come from brand Zepbound: in SURMOUNT-1, the 15 mg dose averaged 20.9% weight loss at 72 weeks [14]. FDA says telehealth sellers may not claim a compounded drug is "clinically proven" to give the same results [5].
Dose, storage and handling
We do not give dosing for compounded vials. The number of units in a dose depends on the concentration printed on your pharmacy label, so follow your prescriber's instructions and the pharmacy label, and ask the pharmacist if anything is unclear. For reference, brand Zepbound starts at 2.5 mg once weekly for 4 weeks, rises in 2.5 mg steps no sooner than every 4 weeks, and tops out at 15 mg [15]. Do not split or change doses on your own.
- How long a vial lasts: FDA says to throw away compounded multi-dose vials 28 days after first use [1].
- Needles: use a new sterile needle and syringe for every dose [1].
- Shipping: do not use an injectable that arrives warm [1].
- Fridge and room temperature: follow the storage line on your pharmacy label. Brand Zepbound single-dose pens and vials may be kept unrefrigerated up to 86 F for 21 days and must not be frozen, but that applies to the brand only [16].
- Where to inject: the brand label lists the abdomen, thigh, or back of the upper arm if someone else injects, rotating sites each week [17].
- Appearance: brand tirzepatide is clear and colorless to slightly yellow [18]. If a compounded vial looks different from what your pharmacy told you to expect, or has particles, call the pharmacist before using it.
What compounded tirzepatide costs
| Program (our verdict) | Price | Includes | Source |
|---|---|---|---|
| IVIM (caution) | $117 a month plus $75 membership | Prepaid 6- or 12-month program | [3] |
| OrderlyMeds (caution) | $149 intro, then $299 a month | Same price every dose | [19] |
| bmiMD (clean) | As low as $179 a month | Plan length not shown | [20] |
| Found (clean) | $239 to $359 per 28 days | Visits; labs extra | [21] |
| Maximus (caution) | $249.99 a month on a 2-month plan | No membership | [22] |
| Direct Meds (caution) | $399 a month | Visit, supplies, shipping | [4] |
| FancyMeds (caution) | $399 per 4 weeks at 4.8 mg | Higher doses cost more | [23] |
HSA and FSA: some programs accept the cards (Remedy Meds says it does) [25]. Whether a given purchase qualifies is a question for your plan administrator.
Where to get it, and where not to
We may earn a commission if you sign up through some links on this page. It never changes a verdict. How we make money
Compounded tirzepatide programs (clean or caution)
- Clean
- Price
- Compounded tirzepatide plan, medication included, per 28 days in cash: $359 (1-month plan), $309 (3-month), $289 (6-month), $239 (12-month). First month on the 1-month plan $219. Checked Oct 17, 2026 [21].
- What you get
- Compounded semaglutide and tirzepatide, brand GLP-1s, and non-GLP-1 drugs. Accepts insurance for visits.
- FDA record
- No FDA warning letter found as of Oct 17, 2026.
- BBB
- BBB profile not checked as of Oct 17, 2026.
- Note
- Billing every 28 days means 13 charges a year. Labs are extra. Membership is refundable only within 3 days or before the first consult. Verdict: clean (provisional). Found review
- Clean
- Price
- Compounded tirzepatide "as low as $179/mo"; plan length not shown. Checked Oct 17, 2026 [20].
- What you get
- Compounded semaglutide and tirzepatide, including microdose plans. Pharmacy not named.
- FDA record
- No FDA warning letter found as of Oct 17, 2026.
- BBB
- BBB profile not checked as of Oct 17, 2026.
- Note
- Refund policy page could not be read. Trustpilot reviewers report warm deliveries and repeat charges. Verdict: clean (provisional). bmiMD review
- Clean
- Price
- GLP-1 program "starts at $179/mo" with visits, medication and supplies included; the page does not say which drug or dose. A $30 consult fee applies to each evaluation that ends in a prescription. Checked Oct 17, 2026 [26] [27].
- What you get
- Compounded semaglutide and tirzepatide from 503A or 503B pharmacies it does not name, plus liraglutide and phentermine.
- FDA record
- No FDA warning letter found as of Oct 17, 2026.
- BBB
- BBB profile not checked as of Oct 17, 2026.
- Note
- Multi-month plans may bill the remaining balance if you cancel. Verdict: clean (provisional). Henry Meds review
- Use caution
- Price
- Compounded tirzepatide $149 a month as a new-customer intro ($299 for 2 months), then $299 a month; a 2-month offer is $449. Same price at every dose; no membership fee. Checked Oct 17, 2026 [19].
- What you get
- Compounded semaglutide and tirzepatide from named 503A pharmacies (SmartPharmaRx, Casa, PerfectRx), plus brand drugs at list-level prices.
- FDA record
- FDA warning letter dated June 8, 2026 [28] for its logo on compounded vial labels and an "FDA-licensed pharmacy" claim. That claim was gone from the main pages on Oct 17, 2026; vial images were not confirmed.
- BBB
- BBB profile not checked as of Oct 17, 2026.
- Note
- Trustpilot average 3.5, with warm deliveries and refused refunds among complaints. The price doubles after the intro. Verdict: caution (provisional). OrderlyMeds review
- Use caution
- Price
- Compounded tirzepatide $399 a month including the physician visit, supplies, shipping and nurse support; no contract. Checked Oct 17, 2026 [4].
- What you get
- Compounded semaglutide and tirzepatide; pharmacy not named.
- FDA record
- FDA warning letter dated Sept 9, 2025 [29] for "same active ingredient" claims. Those phrases were not on its home or pricing page on Oct 17, 2026.
- BBB
- BBB profile not checked as of Oct 17, 2026.
- Note
- Dose tiers are not shown. Verdict: caution (provisional). Direct Meds review
FancyMeds
Use caution- Price
- Compounded tirzepatide at 4.8 mg a week: $399 per 4 weeks standard, promo from $148.99 with conditions not stated; higher doses cost more. Checked Oct 17, 2026 [23].
- What you get
- One-time purchases of compounded semaglutide and tirzepatide; no membership and no auto-renew.
- FDA record
- FDA warning letter dated Sept 9, 2025 [30] for "same active ingredient" and "FDA-monitored" claims. The site now says compounded drugs are not FDA-approved.
- BBB
- BBB profile not checked as of Oct 17, 2026.
- Note
- Full refund before shipment, none after. Pharmacy not named. Verdict: caution (provisional).
- Use caution
- Price
- Compounded tirzepatide $117 a month on a prepaid 6- or 12-month program, plus a $75 monthly membership (first month free); the page does not say how the two combine. Checked Oct 17, 2026 [3].
- What you get
- Long prepaid compounded GLP-1 programs; pharmacy not named.
- FDA record
- FDA warning letter dated Feb 20, 2026 [31] because vial labels said "Ivim", implying it was the compounder. Whether that was fixed is not confirmed.
- BBB
- BBB profile not checked as of Oct 17, 2026.
- Note
- Cancelling a program costs $100 per unshipped 3-month portion [32]. Verdict: caution (provisional). IVIM review
We rate these sellers of compounded tirzepatide avoid. TrimRx, which people ask about, sells compounded semaglutide and tirzepatide [33].
- MedVi: BBB rating F with 751 complaints, 135 unanswered [34]; FDA warning letter dated Feb 20, 2026 [35]. Read our MedVi review
- TrimRx: BBB rating F and a BBB "pattern of complaints" alert: 2,598 complaints in 3 years about billing and cancellations [36]. Read our TrimRx review
- Fridays: BBB rating F; 65 complaints in the last 12 months, 63 unanswered, mostly billing and refunds [37]. Read our Fridays review
- Shed (ShedRx): 257 BBB complaints in 3 years about undelivered orders, refused refunds and blocked cancellations [38]. Read our Shed (ShedRx) review
- Mochi Health: Washington regulators issued a Notice of Immediate Jeopardy to its compounding partner, Aequita Pharmacy [39]; Eli Lilly is suing Mochi [40]. Read our Mochi Health review
Different from "research use only" vials
Compounded tirzepatide comes from a licensed pharmacy with a prescription. Vials sold online as "research use only" are neither, and FDA has warned their sellers [1]. See research-use-only GLP-1s.
Tirzepatide safety facts
The tirzepatide label carries a boxed warning for thyroid C-cell tumors in rats; do not use it with a personal or family history of medullary thyroid carcinoma or MEN 2 [18]. Get care for severe stomach pain that will not go away (possible pancreatitis) or signs of a serious allergic reaction. Low blood sugar is more likely with insulin or a sulfonylurea. Stop when pregnancy is recognized [18]. Call 911 in an emergency.
Related: how Zepbound and Mounjaro compare, tirzepatide overview, compounded semaglutide.
Questions people ask
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved, and FDA does not review it for safety, effectiveness or quality [1].
Is compounded tirzepatide legal?
Only in narrow cases. Since 503A compounding tolerance ended March 5, 2025, a pharmacy may compound it for an individual patient, and copies of Zepbound or Mounjaro are barred unless the prescriber documents a significant difference for that patient; 503B facilities cannot compound it from bulk [2].
Can you still get compounded tirzepatide?
How much does compounded tirzepatide cost?
Is compounded tirzepatide safe?
FDA does not review it, had more than 730 adverse event reports for it as of May 31, 2026, and has warned about dosing errors with compounded GLP-1 vials [1].
What is the starting dose of compounded tirzepatide?
There is no FDA-approved dose for a compounded product; your prescriber sets it, and the units depend on the concentration on your pharmacy label. Brand Zepbound starts at 2.5 mg once weekly for 4 weeks [15]. Ask your pharmacist if the label is unclear.
How long does compounded tirzepatide last once opened?
FDA advises discarding compounded multi-dose GLP-1 vials 28 days after first use, using a new sterile needle and syringe each time, and not using an injectable that arrives warm [1].
Does TrimRx use compounded tirzepatide?
Where do compounding pharmacies get tirzepatide?
They buy the active ingredient in bulk. Since Sept 5, 2025, FDA's green list import alert allows GLP-1 ingredients from facilities not on the list to be detained at the border [7].
Sources
40 cited
- FDA's concerns with unapproved GLP-1 drugs used for weight loss. US Food and Drug Administration, Oct 1, 2026.
- FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. US Food and Drug Administration, Apr 1, 2026.
- IVIM Health home page and prices. Ivim, Oct 17, 2026.
- DirectMeds pricing. DirectMeds, Oct 17, 2026.
- For telehealth companies: what to know when promoting compounded drugs. US Food and Drug Administration, Jun 15, 2026.
- Warning letter: Empower Clinic Services, LLC dba Empower Pharmacy. US Food and Drug Administration, Sep 18, 2026.
- FDA launches green list to protect Americans from illegal imported GLP-1 drug ingredients. US Food and Drug Administration, Sep 5, 2025.
- Warning letter: Remedy Meds. US Food and Drug Administration, Sep 9, 2025.
- FDA intends to take action against non-FDA-approved GLP-1 drugs. US Food and Drug Administration, Feb 6, 2026.
- FDA warns 30 telehealth companies against illegal marketing of compounded GLP-1s. US Food and Drug Administration, Mar 3, 2026.
- FDA compounded GLP-1 telehealth marketing warning letters. Spakinect, Jun 18, 2026.
- Fifth Circuit upholds FDA GLP-1 shortage decisions. Clark Hill, Sep 10, 2026.
- Court sides with FDA in tirzepatide shortage fight: 5 notes. Becker's Hospital Review, Sep 2, 2026.
- Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine (PubMed), Jun 4, 2022.
- Zepbound (tirzepatide) prescribing information. DailyMed, NLM/NIH, Aug 2026.
- Zepbound Medication Guide. DailyMed, NLM/NIH, Aug 2026.
- Mounjaro (tirzepatide) prescribing information. DailyMed, NLM/NIH, Aug 2026.
- Zepbound prescribing information (217806 s050). US Food and Drug Administration, Apr 2026.
- OrderlyMeds pricing. OrderlyMeds LLC, Oct 17, 2026.
- bmiMD home page and prices. bmiMD, Oct 17, 2026.
- Found offer terms. Found Health, Inc., Oct 17, 2026.
- Maximus home page and prices. Maximus Health, Inc., Oct 17, 2026.
- FancyMeds tirzepatide. FancyMeds, Oct 17, 2026.
- Zepbound on LillyDirect: self-pay prices. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
- Remedy Meds terms of service. Remedy Meds, Oct 17, 2026.
- Henry Meds GLP-1 weight management. Henry Meds, Oct 17, 2026.
- Henry Meds refund, return and replacement policy. Henry Meds, Oct 17, 2026.
- Warning letter: OrderlyMeds LLC dba OrderlyMeds. US Food and Drug Administration, Jun 8, 2026.
- Warning letter: directmeds.com, Inc. dba DirectMeds. US Food and Drug Administration, Sep 9, 2025.
- Warning letter: Fancy Meds, LLC dba Fancy Meds. US Food and Drug Administration, Sep 9, 2025.
- Warning letter: Ivim Services LLC dba Ivim. US Food and Drug Administration, Feb 20, 2026.
- IVIM refunds and returns. Ivim, Oct 17, 2026.
- TrimRx vs Hims cost and pricing (TrimRx blog). TrimRx, May 20, 2026.
- MedVi BBB profile. Better Business Bureau, Oct 17, 2026.
- Warning letter: MEDVi, LLC dba MEDVi. US Food and Drug Administration, Feb 20, 2026.
- TrimRx BBB profile. Better Business Bureau, Oct 17, 2026.
- Thrive Health Group (Fridays) BBB profile. Better Business Bureau, Oct 17, 2026.
- Shed BBB profile. Better Business Bureau, Oct 17, 2026.
- Mochi Health weight loss drugs under scrutiny. NBC Bay Area, Jun 4, 2026.
- Eli Lilly lawsuit against weight loss drug seller gets another shave. Courthouse News Service, Sep 8, 2026.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.